Publishing research using ab91497? Please let us know so that we can cite the reference in this datasheet.

ab91497 has been referenced in 6 publications.

  • Han WR  et al. Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts. Transpl Immunol 7:207-13 (1999). PubMed: 10638833
  • Kinnaert P  et al. Role of CD18-dependent and CD18-independent mechanisms in the increased leukocyte adhesiveness and in the variations of circulating white blood cell populations induced by anti-CD3 monoclonal antibodies. Transpl Int 9:386-91 (1996). PubMed: 8819275
  • Vossen AC  et al. Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects. Eur J Immunol 25:1492-6 (1995). PubMed: 7614975
  • Henrickson M  et al. Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11). Transplantation 60:828-35 (1995). PubMed: 7482743
  • Leo O  et al. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A 84:1374-8 (1987). PubMed: 2950524
  • Samelson LE  et al. T cell antigen receptor phosphorylation induced by an anti-receptor antibody. J Immunol 139:2708-14 (1987). PubMed: 2443570

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"